# Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old

> **NCT00780741** · PHASE3 · COMPLETED · sponsor: **Jaeb Center for Health Research** · enrollment: 220 (actual)

## Conditions studied

- Nasolacrimal Duct Obstruction

## Interventions

- **PROCEDURE:** Immediate Office Probing
- **PROCEDURE:** Deferred Facility Probing

## Key facts

- **NCT ID:** NCT00780741
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-11
- **Final completion:** 2012-01
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2016-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00780741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00780741, "Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00780741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
